(Q40045695)

16 September 2017

title

The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome (English)

1 reference

16 September 2017

N L Meyers

1

1 reference

16 September 2017

R I Hickling

series ordinal

2

1 reference

16 September 2017

publication date

1 November 2007

1 reference

Journal of International Medical Research

16 September 2017

published in

1 reference

16 September 2017

volume

35

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

848-866

1 reference

Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Human pharmacology of renzapride: a new gastrokinetic benzamide without dopamine antagonist properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Effect of renzapride on transit in constipation-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Cisapride. Drug interactions of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Variability of heart rate correction methods for the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Effects of three fluoroquinolones on QT interval in healthy adults after single doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Investigation of the effects of physiological and vasodilation-induced autonomic activation on the QTc Interval in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

The influence of age and gender on the pharmacokinetics of moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000703500613

10.1177/147323000703500613

21 January 2018

Identifiers

DOI

1 reference

release_ygfcmbrlebcbdg2qdtcbt7xdc4

16 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ygfcmbrlebcbdg2qdtcbt7xdc4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference